ConductScience.org, home

Paper41892463

Prescribing Patterns and Clinical Outcomes of Ceftolozane/Tazobactam by Renal Function and Body Mass Index: A SPECTRA Real-World Multi-Country Analysis.

Yucel E and 7 others. Antibiotics (Basel), 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prescribing Patterns and Clinical Outcomes of Ceftolozane/Tazobactam by Renal Function and Body Mass Index: A SPECTRA Real-World Multi-Country Analysis. Papers, record 41892463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41892463

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prescribing Patterns and Clinical Outcomes of Ceftolozane/Tazobactam by Renal Function and Body Mass Index: A SPECTRA Real-World Multi-Country Analysis.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yucel EEmrehttps://orcid.org/0000-0002-6036-9526
2Soriano AAlexhttps://orcid.org/0000-0002-9374-0811
3Thalhammer FFlorianhttps://orcid.org/0000-0001-6523-8229
4Kluge SStefan
5Allen MMike
6Levy JJessica
7Yang HHuina
8Kaul SSunny

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N/AMerck Sharp & Dohme LLCPubMed

Source PubMed

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,647,284Infections and immunity: associations with obesity and related metabolic disorders.J Pathol Transl Med2023https://conductscience.org/library/papers/36647284PubMed
233,831,296Obesity and chronic kidney disease: prevalence, mechanism, and management.Clin Exp Pediatr2021https://conductscience.org/library/papers/33831296PubMed
329,934,432Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles.Clin J Am Soc Nephrol2018https://conductscience.org/library/papers/29934432PubMed
438,526,051Updated antimicrobial dosing recommendations for obese patients.Antimicrob Agents Chemother2024https://conductscience.org/library/papers/38526051PubMed
538,570,631Chronic kidney disease and the global public health agenda: an international consensus.Nat Rev Nephrol2024https://conductscience.org/library/papers/38570631PubMed
636,551,426Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review.Antibiotics (Basel)2022https://conductscience.org/library/papers/36551426PubMed
736,498,473
Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation.
J Clin Med2022https://conductscience.org/library/papers/36498473PubMed
840,493,357FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making.Clin Pharmacol Ther2025https://conductscience.org/library/papers/40493357PubMed
935,625,223New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review.Antibiotics (Basel)2022https://conductscience.org/library/papers/35625223PubMed
1022,242,561Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs.Br J Clin Pharmacol2012https://conductscience.org/library/papers/22242561PubMed
1140,578,553Real-world analysis of ceftolozane/tazobactam prescribing patterns and effectiveness: SPECTRA analysis on chronic pulmonary diseases and respiratory-related infections.J Glob Antimicrob Resist2025https://conductscience.org/library/papers/40578553PubMed
1238,354,125Impact of obesity on intensive care unit outcomes in older patients with critical illness: A cohort study.PLoS One2024https://conductscience.org/library/papers/38354125PubMed
1326,530,985A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.Trials2015https://conductscience.org/library/papers/26530985PubMed
1434,234,480Relationship Between Multidrug-Resistant Enterobacterales and Obesity in Older Adults.Infect Drug Resist2021https://conductscience.org/library/papers/34234480PubMed
1539,864,656Unveiling results and insights from multinational, multicenter Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA).J Glob Antimicrob Resist2025https://conductscience.org/library/papers/39864656PubMed
1639,864,430A New Era in the Management of Cardiorenal Syndrome: The Importance of Cardiorenal Units.Cardiorenal Med2025https://conductscience.org/library/papers/39864430PubMed
1731,086,308Antimicrobial resistance in nephrology.Nat Rev Nephrol2019https://conductscience.org/library/papers/31086308PubMed
1835,058,571Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition.Int J Obes (Lond)2022https://conductscience.org/library/papers/35058571PubMed
1940,348,149Beyond the binary: integrating "real-world evidence" with randomized trials in contemporary health care.J Clin Epidemiol2025https://conductscience.org/library/papers/40348149PubMed
2039,955,850A real-world investigation into prescribing patterns and effectiveness of ceftolozane/tazobactam among critically ill patients from SPECTRA.Diagn Microbiol Infect Dis2025https://conductscience.org/library/papers/39955850PubMed

See all 21 references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SH2D1A4,068PubTator's text mininghttps://conductscience.org/library/genes/4068

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41892463

GET https://conductscience.org/api/papers/v1/41892463/references?page=2